Medite Cancer Diagnostics Inc (MDIT)

[utterbull]

What makes you think management has anything to lose? Last time management made a purchase was 9/25/05 at .10 cents. Most likely outcome is they will award themselves new options when it is most beneficial to them. With little money rolling in it will be the only way to maintain their interest in the company.

Pay close attention to any SEC filings in the next 6 months, I'm certain they will adjust their stock based compensation to make up for any loses the RS has done. May find it in the 10Q. A side note on the frequent changes in accounting firms, usually means that the old accounting firm refused to fudge the numbers on Cytocore's behalf, think about that!

Most brokers will provide detailed quotes on insider action but you can also find it here:

http://www.cnbc.com/id/15837285?q=cyoe

Funny thing is that one only gets to see who is dumping after the fact since the paper trial of whom they are selling equity interest to is next to nothing. Intentional in my opinion because they don't want retail to know how much they are diluting the float and at what price they are selling.